Penn Medicine study: kidney algorithm reduced Black transplant access
For years, a clinical algorithm used for the national kidney transplant waitlist made Black patients appear healthier than they were, making it harder for them to secure transplant spots. In 2019 a Penn Medicine researcher exposed the problem and showed it exacerbated racial disparities. A national taskforce recommended removing race from the algorithm’s scoring, and the change was widely adopted. Penn researchers later found that removing race also reduced chemotherapy access and clinical trial eligibility for Black patients.
- AI system involved
- kidney function algorithm
1 source article · read the reporting →
U.S. hospitals' race-based eGFR calculation delayed Black kidney patients' transplants
For years, U.S. transplant hospitals used a race-based version of the eGFR equation to estimate Black patients' kidney function. The adjustment inflated Black patients' readings, delaying their referral to the kidney transplant waitlist and leaving some to die or deteriorate on dialysis. After years of advocacy, the United Network for Organ Sharing prohibited the race-based calculation in 2022 and required transplant programmes to revise affected patients' waiting times.
- Company involved
- U.S. transplant hospitals
- AI system involved
- eGFR (estimated glomerular filtration rate)
2 source articles · read the reporting →
Hospital Denies Pain Medication to Patient Based on Narx Score
Elizabeth Amirault, a 34-year-old chronic pain patient, was denied narcotic pain medication during a hospital visit in Fort Wayne, Indiana, in August 2022. A nurse practitioner told her that her Narx Score, generated by Bamboo Health's NarxCare platform, was too high to prescribe opioids. The algorithm uses prescription drug monitoring data to assess risk of misuse, but critics say it can harm patients by cutting off needed care. Amirault believes her score was unfairly high due to her multiple surgeries and doctors.
- AI system involved
- NarxCare
3 source articles · read the reporting →
Robotic surgery complications underreported to FDA, study finds
A Johns Hopkins study found that out of approximately one million robotic surgeries performed since 2000, only 245 complications including 71 deaths were reported to the U.S. Food and Drug Administration. The researchers allege that hospitals and manufacturers often fail to report adverse events as required, and some incidents were only reported after media coverage. The study highlights a lack of transparency and independent data collection for robotic surgery safety.
10 source articles · read the reporting →
